 |
Antithrombin III (human) concentrate IV |
|---|---|
| Trade Name | Kybernin P |
| Orphan Indication | For prophylaxis and treatment of thromboembolic episodes in patients with genetic AT-III deficiency |
| USA Market Approval | USA |
| USA Designation Date | 1985-07-02 00:00:00 |
| Sponsor | CSL Behring;1020 First Ave., PO Box 61501;King of Prussia, Pennsylvania, 19406 |
